A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3

Clinical trial NCT05160558 · TERMINATED

Trial details

NCT number: NCT05160558
Sponsor: Biogen
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Spinocerebellar Ataxia Type 3

Start date: 2022-02-02
Primary completion: 2023-07-25
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.